An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic cancer.

Cell Rep Med · 2024 · PMC10897606 · PMID 38325381

Europe PMC DOI

hedged sentence

0.0000

closest p · 0.0× alpha

0.0000

boldest claim

The sentences

highly significantp = 2.8e−40actually significant

We found a large (n = 98) and highly significant (p = 2.8e−40) overlap between the splicing events regulated by QKI and RBFOX2 ( Figure 4 D).

also in 33,666 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.